S-31 (Elamipretide) 50mg Research Peptide
S-31 (Elamipretide, MTP-131) is a mitochondria-targeting tetrapeptide that selectively accumulates at cardiolipin in the inner mitochondrial membrane. This 50mg bulk vial is designed for extended or multi-model research protocols requiring larger quantities. Purity ≥99%, HPLC and MS/MS verified per batch with third-party COA available.
Research Background
S-31 represents one of the most clinically validated mitochondria-targeting compounds available for research. Its mechanism — cardiolipin stabilization, ROS reduction, and cristae structure preservation — addresses fundamental aspects of mitochondrial dysfunction that are relevant across aging, cardiovascular disease, metabolic disease, and neurodegeneration research contexts. Phase 2 trials in heart failure and primary mitochondrial myopathy have both produced positive primary endpoints.
Compound Specifications
- Format: Lyophilized powder
- Purity: ≥99% (HPLC verified)
- Quantity: 50mg per vial
- Storage: −20°C, protected from light
- Sequence: D-Arg-2′6′-Dmt-Lys-Phe-NH2
Certificate of Analysis
Third-party tested by independent ISO-certified laboratories. HPLC and MS/MS validation performed per batch. COA available on request.
For research and laboratory use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
